Rapidly progressive lung disease in a patient with cystic fibrosis on long-term azithromycin: Possible role of mycoplasma infection

4Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Macrolides is effective therapy in patients with cystic fibrosis (CF). We describe a girl with CF given long-term azithromycin who died of rapidly progressive lung disease. She was found to have rising titers of mycoplasma serology, suggesting a possible causative role of a resistant mycoplasma infection. Mycoplasma infection should be considered in CF patients who are deteriorating, even if they are being treated with macrolides, to which these organisms are usually susceptible. © 2005 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Cite

CITATION STYLE

APA

Janahi, I. A., Abdulwahab, A., Elshafie, S., & Bush, A. (2005). Rapidly progressive lung disease in a patient with cystic fibrosis on long-term azithromycin: Possible role of mycoplasma infection. Journal of Cystic Fibrosis, 4(1), 71–73. https://doi.org/10.1016/j.jcf.2004.11.002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free